CHENGDU, China , Oct. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Lung04 trial of the Company's...
Hence then, the article about positive results from phase 3 optitrop lung04 trial of sacituzumab tirumotecan presented at esmo presidential symposium and simultaneously published in nejm was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM )
Also on site :
- Feds announce 15 arrests in alleged $1.4 million public benefits fraud crackdown
- Taking an omega-3 supplement may not boost memory or cognition
- Julia Fox’s Video of Her Son Trying To Give Donuts to the NYPD at the Knicks Parade Will Make Your Day